Shareholders Unite Blog | Talkmarkets | Page 1

Shareholders Unite

Retired Professor
Contributor's Links: Shareholders Unite

We at Shareholders Unite are retired university professors from Amsterdam writing with a focus on small-cap, macro, value, and momentum.

Our analysis can be read on both TalkMarkets and more

Following: 9 Followers: 1118

All Contributions

Latest Posts
1 to 9 of 9 Posts
E Orgenesis' Leveraged Approach To Lower The Cost Of Cell And Gene Therapies
Monday, December 14, 2020 10:18 AM EST
Orgenesis is an innovative biotech company in the CGT (Cell & Gene Therapy) space.
In this article: ORGS
Read
E Medigus Is Facing Multiple Opportunities But Is Not Without Risk
Tuesday, July 21, 2020 9:06 AM EST
While the company doesn't yet produce much in the way of revenues, it has stakes in multiple interesting opportunities and cash to last for quite a while. This is a high-risk, high-reward type of investment.
In this article: MDGS, SCTC Also: DGSW
Read
E Medigus, A High-Risk, High-Reward Micro-Camera Play
Monday, August 19, 2019 9:00 AM EST
Medigus, is a company producing the highly innovative micro-camera and sensors ScoutCam, orders for which are taking off this year. The company which also produces the MUSE system for GERD treatment, a business which they intent to sell.
In this article: MDGS, SCTC
Read
E Nxt-ID Gets A New Lease On Life
Wednesday, June 5, 2019 4:43 PM EST
Nxt-ID has some promising businesses that are now about to be split with investors receiving shares of their finance business in a tax free distribution. What are the prospects?
In this article: NXTD Also: WMT, GRMN, V, BITCOMP
Read
Teladoc Health Looks Pretty Interesting
Tuesday, May 21, 2019 5:01 AM EST
Teladoc is a big player in the rapidly rising, but still young, virtual care market. The company has multiple growth avenues in front of it but also some challenges which need to be overcome.
In this article: TDOC
Read
Boxlight Is Still Attractive
Monday, May 20, 2019 12:07 PM EST
Despite a disappointing Q1, we think Boxlight is still an attractive buy as the bad quarter isn't likely to be the harbinger of a structural problem.
In this article: BOXL
Read
It's Still Not Too Late To Get On Board Of The BioLife Solutions Train
Friday, May 17, 2019 10:58 AM EST
BLFS) is a stock to benefit from the early innings of regenerative medicine revolution with multiple avenues for growth ahead if it.BLFS
In this article: BLFS
Read
The Real Risk Of The Trade War
Thursday, May 16, 2019 12:15 PM EST
It is difficult to see the Chinese caving to the demands of the Trump government, which seem to involve a wholesale change of China's economic model.
Read
Trump Versus The Dollar, Round 2
Tuesday, January 24, 2017 1:12 PM EST
Trump has argued that the dollar is too strong, and he does have a point. A strong dollar is bad for US exports and corporate earnings, but there are also other ramifications. The problem is, there doesn't seem to be much he can do about it.
In this article: UUP
Read
1 to 9 of 9 Posts